Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Locally Advanced Lung Carcinoma; Locally Advanced Malignant Solid Neoplasm; Locally Advanced Melanoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Stage III Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Other: Electronic Health Record Review Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting

https://clinicaltrials.gov/study/NCT06075524

Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials